Acceptability and Efficacy of Pain Reprocessing Therapy in Racially/ Ethnically Diverse Adults With Chronic Back Pain

Back Pain Clinical Trial

Official title:

Feasibility and Acceptability of Pain Reprocessing Therapy in Racially/ Ethnically Diverse Adults With Chronic Back Pain

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05820204
• Other study ID #: 22-2162
• Status: Recruiting
• Phase: N/A
• Start date: April 12, 2023
• Est. completion date: January 2025

Study information

• Verified date: June 2024
• Source: University of Colorado, Denver
• Contact: Jonathan K. Ashar, Ph.D.
• Phone: 303.724.2536
• Email: yoni.ashar[@]cuanschutz.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this clinical trial is to learn which treatment works better for adults with chronic pain. This study are comparing three treatments: Pain Reprocessing Therapy (PRT), Cognitive Behavioral Therapy (CBT), and usual care (whatever a person is already doing to cope with their pain). The study's main questions are: - Does PRT work well for adults with chronic pain? - Which treatment works better for lowering pain: PRT, CBT, or usual care? This study will compare PRT, CBT, and usual care to see which is most helpful for lowering pain and helping with other problems that people with chronic pain can have.

Description:

Investigators recently developed a novel psychological treatment, pain reprocessing therapy (PRT). Using a combination of cognitive, exposure-based, and somatic psychotherapy techniques, PRT aims to promote patients' reconceptualization of pain as due to reversible, non-dangerous brain activity rather than peripheral pathology. Critically, PRT aims to reduce or eliminate pain, rather than increasing functioning. In the first trial of PRT (N = 151), 66% of patients randomized to PRT were pain-free or nearly so at post-treatment, as compared to fewer than 20% of placebo and usual care controls. This trial was conducted in a primarily White, highly-educated population with face-to-face treatment, and how PRT effects would generalize to a more diverse population or to telehealth treatment is not known. PRT was developed to better address pain intensity and pain-related outcomes compared to leading psychological treatments for pain such as cognitive behavioral therapy (CBT). This study aims to yield preliminary findings on the comparative efficacy of PRT vs. CBT vs. usual care. Developing scalable effective, non-pharmacological chronic pain treatments and testing their efficacy in racial/ethnic minorities is an urgent societal need. Accordingly, this study also tests a remotely-delivered PRT intervention in a diverse patient population. Aim 1 of this study is to test the feasibility (recruitment & retention) of conducting a randomized clinical trial comparing remotely-delivered PRT with an active comparator, CBT, and usual care and to assess the acceptability (helpfulness, satisfaction, & impact) of PRT in a diverse, lower socioeconomic status (SES) patient population. Aim 2 of this study is to test the comparative efficacy of PRT vs. CBT and PRT vs. usual care on pain intensity and other pain-related outcomes.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 75
• Est. completion date: January 2025
• Est. primary completion date: January 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Last-week average back pain of at least 4 of 10 at the two pretreatment timepoints (online pre-screening and informed consent session)
• Back pain that is an ongoing problem for at least half the days of the last 6 months
• Back pain that is worse than leg pain.

Exclusion Criteria:

• Current litigation or compensation associated with pain or plans to apply for compensation or engage in litigation in the next 6 months
• Active suicidal ideation with intent, recent history of suicide attempt, or recent history of suicide attempts or self-harm behaviors within the past 5 years (including non-suicidal self-harm)
• Recent history of inpatient psychiatric hospitalization within the past 5 years
• Active, current psychosis or mania
• Active, current substance abuse, or problems with substance abuse within the past 2 years
• Instability in living conditions or major interfering life events:
• Major surgery or other major medical event planned in coming six months
• Unsure whether will reliably have suitable conditions for telehealth appointments over the next two months, including a computer or tablet, reliable fast internet, and a quiet comfortable room that is reliably available.
• Major, interfering changes in employment or housing anticipated over the next six months
• Failure to complete at least 85% (6 of 7) of EMA surveys in the first week of the study (post-consent, pre-randomization)
• Leg pain worse than back pain
• Back surgery within the last 2 years
• Difficulty controlling bladder function (to screen out cauda equina syndrome)
• Serious medical illness (e.g., current, or recent cancer diagnosis, severe cardiovascular disease)
• Recent large unexplained, unintended weight loss (20lbs or more)
• Recent vertebral fracture/ known spinal fractures or tumors
• Known sensory/motor abnormalities in the trunk or legs.
• Self-reported diagnosis of a specific inflammatory disorder: rheumatoid arthritis, polymyalgia rheumatica, scleroderma, Lupus, or polymyositis

Related Conditions & MeSH terms

• Back Pain
• Chronic Pain
• Pain, Chronic

Intervention

Behavioral:
• Pain reprocessing therapy (PRT)
A promising new psychotherapy for chronic pain
• Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)
A psychotherapy for chronic pain that has 30+ years of research support.

Other:
• Usual care
Participants will be asked to continue to do whatever they are currently doing to manager their pain

Locations

Country	Name	City	State
United States	University of Colorado Anschutz Medical Campus	Aurora	Colorado

Sponsors (1)

Lead Sponsor	Collaborator
University of Colorado, Denver

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain intensity	Last-week average pain intensity is assessed via the Brief Pain Inventory Short Form (BPI-SF). The BPI-SF assess pain severity and its impact on functioning. It consists of 9 total items including 4 pain items and 5 pain interference items. The 4 pain items measure pain in the last week on a numerical rating scale of 0 (no pain at all) to 10 (pain as bad as you can imagine).	Primary time point is the day after post-treatment, 1.5 months on average
Primary	Session Attendance	Session attendance is a feasibility measure calculated as the proportion or percentage of people randomized to either PRT or CBT who attended at least 6 sessions.	This value will be calculated a day after post-treatment for the last participant, approximately 1 year from the start of enrollment
Secondary	Pain interference	Pain interference is assessed via the pain interference items (5-items) of the Brief Pain Inventory Short Form (BPI-SF). The BPI-SF assess pain severity and its impact on functioning. It consists of 9 total items including 4 pain items and 5 pain interference items. The 5 pain interference items measure pain interference in the last week on a numerical rating scale of 0 (does not interfere) to 10 (completely interferes).	Primary time point is the day after post-treatment, 1.5 months on average
Secondary	Depression	Depression is assessed via the 8-item depression sub-scale of the Patient Reported Outcome Measurement Information System Short Form (PROMIS-SF). The PROMIS scale as a whole monitors the physical, mental, and social health of adults and children. Each item in the PROMIS-SF depression sub-scale is rated on a 5-point scale of 1 (never) to 5 (always).	Primary time point is the day after post-treatment, 1.5 months on average
Secondary	Positive Affect	Assessed via the PANAS is a self-report questionnaire that consists of two 10-item scales to measure both positive and negative affect. Each item is rated on a 5-point scale of 1 (not at all) to 5 (very much).	Primary time point is the day after post-treatment, 1.5 months on average
Secondary	Anxiety	Anxiety is assessed via the 8-item anxiety sub-scale of the Patient Reported Outcome Measurement Information System Short Form (PROMIS-SF). The PROMIS scale as a whole monitors the physical, mental, and social health of adults and children. Each item in the PROMIS-SF anxiety sub-scale is rated on a 5-point scale of 1 (never) to 5 (always).	Primary time point is the day after post-treatment, 1.5 months on average
Secondary	Anger	Anger is assessed via the 5-item anger sub-scale of the Patient Reported Outcome Measurement Information System Short Form (PROMIS-SF). The PROMIS scale as a whole monitors the physical, mental, and social health of adults and children. Each item in the PROMIS-SF anger sub-scale is rated on a 5-point scale of 1 (never) to 5 (always).	Primary time point is the day after post-treatment, 1.5 months on average
Secondary	Sleep quality	Sleep quality is assessed via the 8-item sleep disturbance sub-scale of the Patient Reported Outcome Measurement Information System Short Form (PROMIS-SF). The PROMIS scale as a whole monitors the physical, mental, and social health of adults and children. 7 of the 8 items in the PROMIS-SF sleep disturbance sub-scale are rated on a 5-point scale of 1 (not at all) to 5 (very much) while 1 item is rated on a 5-point scale of 1 (very poor) to 5 (very good).	Primary time point is the day after post-treatment, 1.5 months on average
Secondary	Client satisfaction	Client Satisfaction is assessed the Patients' Global Impression of Change (PGIC). The PGIC is a single-item self-report scale that measures a patient's belief about the efficacy of treatment. The single-item is rated on a 7-point scale of 1 (No change or condition has got worse) to 7 (a great deal better).	Primary time point is the day after post-treatment, 1.5 months on average
Secondary	Physical Activity Levels	Physical activity levels are assessed via the 7-item, self-reported International Physical Activity Questionnaire - Short Form (IPAQ-SF). The IPAQ-SF measures sitting times as well as physical activity and their intensities as performed by a participant during the last 7 days. Types of physical activities and their intensities are recorded in time (Hours per day: minutes per day)	Primary time point is the day after post-treatment, 1.5 months on average
Secondary	Medication Use	Medication use is assessed by asking participants to provide the names, dosages, and frequencies of the medications that they are currently taking for pain management only.	Primary time point is the day after post-treatment, 1.5 months on average